Colligan, Erica AMetzler, AbbyTiryaki, Ezgi2016-06-162016-06-162016http://hdl.handle.net/11299/181034A literature review for injectable medications used to treat multiple sclerosis was conducted, specifically targeting two groups of injectable medications: beta-interferon and glatiramer acetate. The Ottawa Hospital Research Institute decision aid methodology was applied to create a patient decision aid for the currently available injectable medications. The benefits and risks of the classes of injectable medications are represented visually. The DA was written at a tenth-grade reading level, and a test of decision comfort (SURE test) was incorporated. Patient education experts, patients, and MS specialists were consulted at various institutions (Hennepin County Medical Center’s Center for Patient and Provider Experience, Mayo Clinic’s Shared Decision Making National Resource Center, a patient panel for chronic disease at the Mayo Clinic, and two local MS physicians). Iterative revisions were done based on feedback from each subject matter expert. The final DA is accessible at the University of Minnesota Digital Conservancy and made available for testing in the clinical setting and for future trials.Attribution-NonCommercial-ShareAlike 3.0 United StatesLearning ObjectAttribution-NonCommercial-ShareAlike 3.0 United States